CNIPA.AI

Company patentsCompare

HEAD TO HEAD

CXMTHengrui Pharma

Technology portfolios compared in the same window and counting units. Scale is compared only within the same field or subclass.

Same window · published 2025-01-01 — 2025-12-31Some name or date coverage is incomplete; affected counts are lower bounds

This is a structural comparison of collected portfolios. The same requested window does not establish equal entity scope, covered months or industry; no competitive ranking is inferred.

Applicant-name coverage differs. The counts below cover only the listed names and do not represent complete company portfolios.

CXMT: Applicant names included in these statistics — CHANGXIN MEMORY TECH INC · CHANGXIN MEMORY TECHNOLOGIES INC · CHANGXIN TECH GROUP CO LTD · CXMT CORPReviewed names not covered — CHANGXIN MEMORY TECHNOLOGIES, INC. · CXMT CORPORATION · 睿力集成电路有限公司 · 长鑫存储技术有限公司 · 长鑫科技集团股份有限公司

Hengrui Pharma: Applicant names included in these statistics — JIANGSU HENGRUI MEDICINE CO · JIANGSU HENGRUI MEDICINE CO LTD · JIANGSU HENGRUI PHARMACEUTICALS CO LTDReviewed names not covered — JIANGSU HENGRUI PHARMACEUTICALS CO., LTD. · 江苏恒瑞医药股份有限公司

Publications
1,570
Invention share
98%
Concentration
0.58
Green technology
—
Publications
618
Invention share
66%
Concentration
1.23
Green technology
—
0.00Field similarity
Cosine similarity of application counts across 35 fields. 1 is identical, 0 is no overlap.

01Technology field mirror

The 12 fields with the largest combined share. Share shows structure; count shows scale.

Technology field mirror
CXMTTechnology fieldHengrui Pharma
0%
Pharmaceuticals
93%
67.9%
Semiconductors
0%
0%
Organic fine chemistry
49.7%
0%
Biotechnology
34.3%
33.6%
Computer technology
0%
5.3%
Basic communication processes
0%
2.3%
Measurement
0.5%
2.2%
Optics
0%
0%
Analysis of biological materials
2%
1.4%
Control
0%
1.2%
Electrical machinery, apparatus, energy
0%
0.3%
Chemical engineering
0.3%

Inspect one technology field

Inspect collected applications, portfolio share and supporting publications within one field. A technology overlap does not establish that companies in different industries are direct competitors.

CXMT

Collected applications
35
Share of collected applications with IPC
2.3%

Coverage is incomplete; counts and shares describe only the collected subset.

View CXMT publications in this field

One application may belong to multiple fields, so shares can sum to more than 100%. Drill-down lists publications; an application publication and its grant may appear separately.

02Same problem: shared IPC subclasses

The 10 subclasses in every company's top 60 with the most combined applications. Scale is compared within a subclass, never across different business scopes.

G01NAnalysing materials
CXMT3
Hengrui Pharma14
B01J
CXMT1
Hengrui Pharma2

03Where each one leans

Observed emphasis within each company’s collected top-60 IPC subclasses. A dash for another company means outside its top-60 list, not zero applications or a market gap. Incomplete coverage can also change the ordering.

CXMT

  • H10BMemory devices
    CXMT
    689
    Hengrui Pharma
    —
  • G11CStatic stores
    CXMT
    480
    Hengrui Pharma
    —
  • H01LSemiconductor devices
    CXMT
    378
    Hengrui Pharma
    —
  • H10D
    CXMT
    220
    Hengrui Pharma
    —
  • H10W
    CXMT
    161
    Hengrui Pharma
    —
  • H10P
    CXMT
    68
    Hengrui Pharma
    —

Hengrui Pharma

  • A61K
    CXMT
    —
    Hengrui Pharma
    539
  • A61P
    CXMT
    —
    Hengrui Pharma
    504
  • C07DHeterocyclic compounds
    CXMT
    —
    Hengrui Pharma
    270
  • C07K
    CXMT
    —
    Hengrui Pharma
    196
  • C12NMicroorganisms, enzymes
    CXMT
    —
    Hengrui Pharma
    70
  • C07C
    CXMT
    —
    Hengrui Pharma
    45

04Publication rhythm

CXMTHengrui PharmaPublications per period
Publications per period
PeriodCXMTHengrui Pharma
2025-01≥233 (partial coverage)≥33 (partial coverage)
2025-02≥180 (partial coverage)≥41 (partial coverage)
2025-03≥99 (partial coverage)≥82 (partial coverage)
2025-04≥79 (partial coverage)≥52 (partial coverage)
2025-05≥108 (partial coverage)≥61 (partial coverage)
2025-06≥177 (partial coverage)≥50 (partial coverage)
2025-07≥156 (partial coverage)≥57 (partial coverage)
2025-08≥112 (partial coverage)≥44 (partial coverage)
2025-09≥148 (partial coverage)≥51 (partial coverage)
2025-10≥89 (partial coverage)≥47 (partial coverage)
2025-11≥64 (partial coverage)≥50 (partial coverage)
2025-12≥125 (partial coverage)≥50 (partial coverage)

Empty dashed outlines mark uncollected periods. Hatched bars and ≥ counts mark partial coverage.

Publication timing follows examination and publication cycles, not R&D intensity.

What makes it comparableThe same publication window and counting units. Companies with different windows are not put in one comparison.

What is not comparableGroup totals. Business and entity scopes differ; compare scale within a field or subclass.

Not a rankingSimilarity and shares describe structure, not patent value, quality or technical leadership.